A study showed that combined treatment with metformin and 2-deoxy-D-glucose (2-DG) led to the AMPK activation and the detachment of MDA-MB-231 cells, which suggested cancer-promoting effects of metformin in breast cancer progression [119]. The gene discussed is PRKAA1; the disease is breast cancer.